Exendin 9-39

DRUG10 trials

Conditions

Appetite and General Nutritional DisordersDiabetes Mellitus With Gastrointestinal SymptomsDumping SyndromeDyspepsiaGastric CancerGenetic PredispositionHealthy VolunteersMonogenic Diabetes

Phase 1

Incretin Regulation of Insulin Secretion in Monogenic Diabetes

CompletedNCT01795144

University of ChicagoMonogenic Diabetes

Start: 2014-01-31End: 2017-03-31Updated: 2017-04-10

Intestinal Glucagon-like Peptide-1 (GLP-1) and the Physiological Role in Eating in Humans

CompletedNCT01900340

University Hospital, Basel, SwitzerlandAppetite and General Nutritional Disorders

Start: 2011-11-30End: 2012-12-31Updated: 2013-07-16

Phase 2

Gastrointestinal Sensorimotor Dysfunctions in Diabetes Mellitus

CompletedNCT02170870

Mayo ClinicDiabetes Mellitus With Gastrointestinal Symptoms, Dyspepsia

Start: 2014-06-30End: 2017-11-17Updated: 2019-04-23

Safety and Efficacy of Exendin 9-39 in Patients With Postbariatric Hypoglycemia

CompletedNCT03373435

Eiger BioPharmaceuticalsPostbariatric Hypoglycemia

Start: 2018-03-19End: 2019-03-15Updated: 2022-07-18

The Role of Islet GLP-1 in the Pathogenesis of Prediabetes

RecruitingNCT06967558

Mayo ClinicPreDiabetes

Start: 2025-11-01End: 2028-03-31Target: 60Updated: 2025-12-15

The Effect of rs7903146 Genotype on Islet GLP-1 Production in Humans

Not yet recruitingNCT06972407

Mayo ClinicGenetic Predisposition, Type2diabetes

Start: 2026-10-01End: 2029-03-01Target: 80Updated: 2026-01-30

Phase 4

Effect of DPP4 Inhibition on Growth Hormone Secretion

CompletedNCT01701973

Vanderbilt UniversityObesity

Start: 2013-01-31End: 2017-05-31Updated: 2018-05-29

Unknown Phase

Influence of Gut Hormones on Food Intake After Roux-en-Y Gastric Bypass Surgery

CompletedNCT02336659

Hvidovre University HospitalSevere Obesity

Start: 2014-04-30End: 2016-06-30Updated: 2016-06-21

Glucagon Like Peptide-1 in Remote Ischemic Conditioning

CompletedNCT02746757

Karolinska InstitutetHealthy Volunteers

Start: 2015-05-31End: 2018-01-31Updated: 2018-03-07

Gastrectomy, Eating Behaviour and GLP-1

CompletedNCT02971631

Cambridge University Hospitals NHS Foundation TrustDumping Syndrome, Gastric Cancer

Start: 2017-08-10End: 2018-09-16Updated: 2019-08-29

Related Papers

OR20-5 28-Day Dosing with Avexitide Improves Hyperinsulinemic Hypoglycemia in Patients with Severe, Refractory Post-Bariatric Hypoglycemia: The PREVENT Study

Journal of the Endocrine Society2019-04-01

Dipeptidyl Peptidase‐4 Inhibition Potentiates Stimulated Growth Hormone Secretion and Vasodilation in Women

Journal of the American Heart Association2018-02-269 citations